Life Sciences

Texas considers disclosure law

Pharma Compliance Alert, January 14, 2009

Texas may join a handful of states that require pharmaceutical companies to disclose payments to healthcare professionals, according to a Dallas Morning News article.

Two separate bills introduced in Texas would require pharmaceutical manufacturers to submit an annual list of all payments to healthcare professionals, including those for consulting fees, honoraria, and gifts. One of those bills would also require disclosures by medical device manufacturers. Companies that fail to report payments could face fines and penalties.

The Texas measures mirror attempts by Congress to create a national registry of pharmaceutical company payments to physicians. Senator Charles Grassley (R-IA) first introduced the Physician Payments Sunshine Act in 2007 and plans to reintroduce in this year. Five states—Vermont, Massachusetts, Minnesota, West Virginia, Maine—plus the District of Columbia currently have payment disclosure requirements in place, while other states enacted laws requiring companies to adopt compliance programs and disclose drug prices.


0 comments on “Texas considers disclosure law


Most Popular